Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited (GLENMARK) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals
glenmarkpharma.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Stock price
₹2459.00
Market cap
69,404 Cr
Stock P/E
43.6
P/B
6.60
Dividend yield
0.2%
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3,207 Cr | 2,507 Cr | 3,063 Cr | 3,244 Cr | 3,434 Cr | 3,388 Cr | 3,256 Cr | 3,264 Cr | 6,047 Cr | 3,901 Cr | 3,771 Cr | 4,018 Cr |
| Operating expenses (approx.) | 2,745 Cr | 2,715 Cr | 2,559 Cr | 2,656 Cr | 2,832 Cr | 2,787 Cr | 2,695 Cr | 2,684 Cr | 3,687 Cr | 3,031 Cr | 3,008 Cr | 3,214 Cr |
| EBITDA | 462 Cr | -209 Cr | 504 Cr | 588 Cr | 602 Cr | 600 Cr | 561 Cr | 581 Cr | 2,360 Cr | 870 Cr | 763 Cr | 805 Cr |
| OPM % | 14.4% | -8.3% | 16.5% | 18.1% | 17.5% | 17.7% | 17.2% | 17.8% | 39.0% | 22.3% | 20.2% | 20.0% |
| Other income | 2 Cr | 45 Cr | 773 Cr | 31 Cr | 39 Cr | 31 Cr | 12 Cr | 26 Cr | 201 Cr | 44 Cr | 189 Cr | 66 Cr |
| Interest | 121 Cr | 134 Cr | 149 Cr | 40 Cr | 48 Cr | 52 Cr | 67 Cr | 58 Cr | 66 Cr | 41 Cr | 43 Cr | 54 Cr |
| Depreciation | 141 Cr | 147 Cr | 151 Cr | 118 Cr | 120 Cr | 123 Cr | 125 Cr | 130 Cr | 141 Cr | 154 Cr | 148 Cr | 173 Cr |
| Profit before tax | 33 Cr | -361 Cr | 562 Cr | 462 Cr | 473 Cr | 456 Cr | 8 Cr | 96 Cr | 967 Cr | 534 Cr | 388 Cr | 643 Cr |
| Tax % | 171.7% | 19.9% | 314.9% | 26.4% | 25.0% | 23.7% | 45.0% | 50.9% | 36.9% | 24.5% | 22.3% | 25.0% |
| Net profit | -64 Cr | -331 Cr | -1,214 Cr | 340 Cr | 354 Cr | 348 Cr | 4 Cr | 47 Cr | 610 Cr | 403 Cr | 301 Cr | 483 Cr |
| EPS (₹) | ₹-2.90 | ₹-12.45 | ₹-43.18 | ₹12.06 | ₹12.55 | ₹12.33 | ₹0.16 | ₹1.66 | ₹21.63 | ₹14.29 | ₹10.68 | ₹17.11 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 9,865 Cr | 10,641 Cr | 10,944 Cr | 12,305 Cr | 12,990 Cr | 11,813 Cr | 13,322 Cr | 16,983 Cr | Sign in for TTM |
| Operating expenses (approx.) | 8,280 Cr | 8,943 Cr | 8,860 Cr | 9,985 Cr | 10,712 Cr | 10,618 Cr | 10,970 Cr | 12,410 Cr | Sign in for TTM |
| EBITDA | 1,586 Cr | 1,698 Cr | 2,084 Cr | 2,320 Cr | 2,278 Cr | 1,195 Cr | 2,351 Cr | 4,572 Cr | Sign in for TTM |
| OPM % | 16.1% | 16.0% | 19.0% | 18.9% | 17.5% | 10.1% | 17.7% | 26.9% | Sign in for TTM |
| Other income | 208 Cr | 160 Cr | 50 Cr | 167 Cr | 317 Cr | 840 Cr | 114 Cr | 461 Cr | Sign in for TTM |
| Interest | 335 Cr | 377 Cr | 353 Cr | 298 Cr | 350 Cr | 516 Cr | 207 Cr | 209 Cr | Sign in for TTM |
| Depreciation | 326 Cr | 417 Cr | 444 Cr | 487 Cr | 611 Cr | 582 Cr | 486 Cr | 573 Cr | Sign in for TTM |
| Profit before tax | 1,301 Cr | 1,096 Cr | 1,382 Cr | 1,441 Cr | 868 Cr | 569 Cr | 1,399 Cr | 1,985 Cr | Sign in for TTM |
| Tax % | 28.9% | 29.2% | 29.8% | 31.1% | 56.5% | 328.1% | 25.2% | 31.4% | Sign in for TTM |
| Net profit | 925 Cr | 776 Cr | 970 Cr | 994 Cr | 377 Cr | -1,434 Cr | 1,047 Cr | 1,362 Cr | Sign in for TTM |
| EPS (₹) | ₹32.78 | ₹27.50 | ₹34.38 | ₹33.37 | ₹10.53 | ₹-53.22 | ₹37.11 | ₹48.26 | Sign in for TTM |
| Dividend payout % | — | — | — | 9.3% | 36.2% | — | 6.7% | 10.4% | Sign in for TTM |
Sign in for TTM
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 28 Cr | 28 Cr | 28 Cr | 28 Cr | 28 Cr | 28 Cr | 28 Cr | 28 Cr |
| Reserves | 5,577 Cr | 6,042 Cr | 7,036 Cr | 9,058 Cr | 9,446 Cr | 7,820 Cr | 8,821 Cr | 10,484 Cr |
| Borrowings | 3,877 Cr | 4,486 Cr | 4,402 Cr | 3,670 Cr | 4,348 Cr | 991 Cr | 2,194 Cr | — |
| Other liabilities | 3,807 Cr | 4,129 Cr | 4,137 Cr | 3,975 Cr | 5,185 Cr | 5,520 Cr | 5,006 Cr | 9,396 Cr |
| Total liabilities | 13,289 Cr | 14,685 Cr | 15,604 Cr | 17,083 Cr | 19,372 Cr | 14,359 Cr | 16,050 Cr | 19,908 Cr |
| Fixed assets (net) | 2,098 Cr | 2,978 Cr | 2,958 Cr | 3,691 Cr | 3,904 Cr | 3,118 Cr | 3,319 Cr | 3,890 Cr |
| CWIP | 1,234 Cr | 1,091 Cr | 1,218 Cr | 921 Cr | 1,115 Cr | 419 Cr | 542 Cr | 428 Cr |
| Investments | 30 Cr | 25 Cr | 25 Cr | 50 Cr | 45 Cr | 790 Cr | 56 Cr | 42 Cr |
| Inventories | 2,252 Cr | 2,136 Cr | 2,277 Cr | 2,500 Cr | 2,978 Cr | 2,513 Cr | 3,029 Cr | 3,431 Cr |
| Trade receivables | 2,195 Cr | 2,409 Cr | 2,572 Cr | 3,101 Cr | 4,099 Cr | 1,858 Cr | 3,342 Cr | 4,963 Cr |
| Cash & bank | 936 Cr | 1,110 Cr | 1,138 Cr | 1,411 Cr | 1,443 Cr | 1,658 Cr | 1,676 Cr | 1,175 Cr |
| Other assets | 4,544 Cr | 4,937 Cr | 5,416 Cr | 5,410 Cr | 5,788 Cr | 4,002 Cr | 4,086 Cr | 5,979 Cr |
| Total assets | 13,289 Cr | 14,685 Cr | 15,604 Cr | 17,083 Cr | 19,372 Cr | 14,359 Cr | 16,050 Cr | 19,908 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | 1,109 Cr | 625 Cr | -265 Cr | -828 Cr | 3,445 Cr |
| Cash from investing | — | — | — | -333 Cr | -528 Cr | 4,369 Cr | 2 Cr | -1,283 Cr |
| Cash from financing | — | — | — | -520 Cr | -77 Cr | -3,906 Cr | 787 Cr | -2,709 Cr |
| Net cash flow | — | — | — | 272 Cr | 33 Cr | 215 Cr | 17 Cr | -501 Cr |
| Free cash flow (OCF − Capex) | — | — | — | 319 Cr | 18 Cr | -1,164 Cr | -1,577 Cr | 2,087 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020BSE balance sheet (this exchange's own filing had none for this period) | Mar 2021BSE balance sheet (this exchange's own filing had none for this period) | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 29.2% | 24.3% | 15.1% | 13.3% | 8.6% | 12.3% | 14.5% | 20.9% |
| ROE % | 0.0% | 0.0% | 14.9% | 11.0% | 0.0% | -19.1% | 11.8% | 0.0% |
| Debtor days | 81 | 83 | 86 | 92 | 115 | 57 | 91 | 106 |
| Inventory days | 335 | 307 | 264 | 278 | 302 | 290 | 367 | 422 |
| Days payable | 331 | 305 | 260 | 254 | 242 | 293 | 313 | 460 |
| Cash conversion cycle | 86 | 84 | 90 | 115 | 174 | 55 | 146 | 68 |
| Debt / equity | 0.69 | 0.74 | 0.62 | 0.00 | 0.46 | 0.13 | 0.25 | — |
| Current ratio | 1.67 | 1.65 | 1.75 | 1.77 | 1.96 | 1.28 | 1.56 | 1.77 |
| Net debt / EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | 1.27 | -0.56 | 0.22 | -0.26 |
Compare with peers
Loading peers…